☆ 4.7 Article

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease

JOURNAL OF NEUROINFLAMMATION (2022)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology

Amy M. Smith et al.

Summary: The study reveals significant differences in gene expression in astrocytes and microglia in the brains of AD patients, correlated with amyloid-beta or pTau expression. There are distinct gene expression patterns in the two cell types and pathologies, but common gene sets exist in each cell type. Additionally, different sub-clusters are found in astrocytes and microglia, characterized by transcriptional signatures related to either homeostatic functions or disease pathology.

ACTA NEUROPATHOLOGICA (2022)

Add to Collection

Article Immunology

Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function

Danyang He et al.

Summary: This study reveals that cellular metabolism regulates microglial function during neurodevelopment. The IL-33 signaling axis, coupled with AKT activity, promotes mitochondrial metabolism and phagocytic function in microglia. This microglia-astrocyte circuit plays a crucial role in the metabolic adaptation and phagocytic function of microglia during early development.

IMMUNITY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum

Victor L. Villemagne et al.

Summary: A neuroinflammatory reaction in AD brains involves reactive astrocytes that overexpress MAO-B. The PET tracer 18F-SMBT-1 showed significantly higher binding in A beta+ CN individuals and A beta+ AD patients compared to A beta-CN individuals. These findings suggest that 18F-SMBT-1 binding can be detected at the preclinical stages of A beta accumulation, supporting its use as a surrogate marker of astrogliosis in the AD continuum.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

Nicholas R. Livingston et al.

Summary: Post-mortem neuropathology suggests that astrocyte reactivity may play a significant role in neurodegeneration in Alzheimer's disease. A study using multimodal PET and MRI imaging found differences in astrocyte reactivity between cognitively impaired patients and healthy controls, with Aβ-positive patients showing greater C-11-BU99008 uptake. These findings suggest a relationship between sustained pro-inflammatory astrocyte reactivity, amyloid deposition, and neuropathology in Alzheimer's disease.

MOLECULAR PSYCHIATRY (2022)

Add to Collection

Review Cell Biology

Glial cells in Alzheimer?s disease: From neuropathological changes to therapeutic implications

Lee Wei Lim et al.

Summary: Alzheimer's disease is a neurodegenerative disorder with unclear pathogenesis. Recent research suggests that microglia and astrocytes may play a role in the development of AD and could be potential therapeutic targets.

AGEING RESEARCH REVIEWS (2022)

Add to Collection

Article Clinical Neurology

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

Estrella Morenas-Rodriguez et al.

Summary: This study aimed to investigate the associations between soluble TREM2, a biomarker of TREM2 signaling, and amyloid beta deposition, tau-related pathology, neuroimaging markers, and cognitive decline in the progression of Alzheimer's disease. The results demonstrated that increased soluble TREM2 was associated with amyloid beta deposition, tau pathology, cortical shrinkage, and cognitive decline.

LANCET NEUROLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Targeted deletion of Interleukin-3 results in asthma exacerbations

Julia Kolle et al.

Summary: The study found that increased IL-3 secretion in PBMCs of asthmatic children was directly related to improved lung function. IL-3(-/-) asthmatic mice exhibited increased asthmatic traits. Additionally, IL-3-deficient mice had a defect in T regulatory cells in the lung.

ISCIENCE (2022)

Add to Collection

Article Immunology

NFIL3 and its immunoregulatory role in rheumatoid arthritis patients

Juping Du et al.

Summary: This study found that the expression level of nuclear-factor, interleukin 3 regulated (NFIL3) is significantly increased in rheumatoid arthritis (RA) patients, and its expression is correlated with abnormal inflammatory cytokines and inflammatory responses. NFIL3 is involved in the regulation of multiple signaling pathways and is positively correlated with key genes associated with RA.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression

Colin Valet et al.

Summary: This study found that the spleen is the major site of platelet production during sepsis, and IL-3 can induce differentiation of megakaryocytes into immunomodulatory platelets. Transfusions of these platelets can enhance immune responses and reduce mortality in sepsis-challenged animals.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Article Biochemistry & Molecular Biology

SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation

Javier Rueda-Carrasco et al.

Summary: Neuroinflammation is a common feature of many neurodegenerative diseases. SFRP1, a multifunctional regulator of cell-to-cell communication, plays a role in promoting and sustaining microglial activation in mouse models of acute and chronic neuroinflammation, representing a potential therapeutic target for counteracting chronic inflammation in neurodegenerative diseases.

EMBO REPORTS (2021)

Add to Collection

Review Immunology

Microglia: Immune and non-immune functions

Katharina Borst et al.

Summary: Microglia, as resident macrophages of the CNS, play crucial roles in maintaining brain homeostasis and responding to disease, through intricate bidirectional communication with other brain cells and infiltrating peripheral immune cells. This harmonious cell-cell communication is essential for maintaining tissue health and overcoming pathology such as neuroinflammation.

IMMUNITY (2021)

Add to Collection

Review Immunology

Astrocyte-immune cell interactions in physiology and pathology

Rafael T. Han et al.

Summary: This article reviews the various functions of astrocytes and their changes in reactive states, emphasizing interactions between astrocytes and microglia, vasculature, and protective barriers in the CNS, as well as discussing recent insights into different sub-states of astrocytes identified by transcriptional profiling. The goal is to stimulate research on how molecular identifiers link to specific functional changes in astrocytes and to define the implications of these heterogeneous molecular and functional changes in brain function and pathology, with the potential to lead to new therapies in CNS injury, infection, and disease.

IMMUNITY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load

Valeria Calsolaro et al.

Summary: This study utilized a novel PET tracer, C-11-BU99008, to investigate astrocyte reactivity associated with Alzheimer's disease, revealing significantly increased astrocyte reactivity in older cognitively impaired and Alzheimer's disease patients, particularly in cortical regions.

MOLECULAR PSYCHIATRY (2021)

Add to Collection

Article Multidisciplinary Sciences

Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease

Cameron S. McAlpine et al.

Summary: Communication within the glial cell ecosystem is essential for neuronal and brain health. This study demonstrates that astrocyte-sourced interleukin-3 programs microglia to ameliorate the pathology of Alzheimer's disease by enhancing their ability to clear aggregates of beta-amyloid and tau, ultimately restricting disease progression and cognitive decline. These findings highlight IL-3 as a key mediator of astrocyte-microglia cross-talk and a potential therapeutic target for Alzheimer's disease.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Microglial activation and tau propagate jointly across Braak stages

Tharick A. Pascoal et al.

Summary: The study found a correlation between microglial activation and tau accumulation in patients with Alzheimer's disease, following a Braak-like pattern. The co-occurrence of A β, tau, and microglial abnormalities was identified as the strongest predictor of cognitive impairment in the study population.

NATURE MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Developing the ATX(N) classification for use across the Alzheimer disease continuum

Harald Hampel et al.

Summary: Breakthroughs in highly accurate fluid and neuroimaging biomarkers have transformed the conceptual approach to Alzheimer's disease from symptom-based to a clinical-biological construct. The AT(N) and evolving ATX(N) systems play crucial roles in categorizing individuals and potential applications in clinical trials and future practice. Current challenges include validation, standardization, and real-world application of these systems.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Regulation of beta-amyloid production in neurons by cholesterol

Hao Wang et al.

Summary: The study shows that apoE uses astrocyte-derived cholesterol to traffic neuronal APP in and out of lipid clusters, generating A beta peptide. Deletion of astrocyte cholesterol synthesis reduces amyloid and tau burden in a mouse model of AD, indicating that cholesterol is kept low in neurons and astrocytes regulate A beta accumulation through cholesterol signaling.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Review Immunology

Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls

Emanuele F. Osimo et al.

BRAIN BEHAVIOR AND IMMUNITY (2020)

Add to Collection

Review Neurosciences

Astrocytes and Microglia: In Sickness and in Health

Ilia D. Vainchtein et al.

TRENDS IN NEUROSCIENCES (2020)

Add to Collection

Article Neurosciences

Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study

Ling-Zhi Ma et al.

MOLECULAR NEURODEGENERATION (2020)

Add to Collection

Review Neurosciences

Astrocyte Crosstalk in CNS Inflammation

Mathias Linnerbauer et al.

NEURON (2020)

Add to Collection

Article Hematology

Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease

John E. Mindur et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Aβ-induced vulnerability propagates via the brain's default mode network

Tharick A. Pascoal et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

CELL (2019)

Add to Collection

Article Neurosciences

Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid- pathology

Marc Suarez-Calvet et al.

MOLECULAR NEURODEGENERATION (2019)

Add to Collection

Review Neurosciences

Astrocyte function from information processing to cognition and cognitive impairment

Mirko Santello et al.

NATURE NEUROSCIENCE (2019)

Add to Collection

Article Clinical Neurology

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Oskar Hansson et al.

ALZHEIMERS & DEMENTIA (2018)

Add to Collection

Article Psychiatry

Interleukin-3, symptoms and cognitive deficits in first-episode drug-naive and chronic medicated schizophrenia

Mei-Hong Xiu et al.

PSYCHIATRY RESEARCH (2018)

Add to Collection

Review Clinical Neurology

TREM2-a key player in microglial biology and Alzheimer disease

Tyler K. Ulland et al.

NATURE REVIEWS NEUROLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

Marc Suárez‐Calvet et al.

EMBO Molecular Medicine (2018)

Add to Collection

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Add to Collection

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Add to Collection

Article Medicine, Research & Experimental

IL-3 promotes the development of experimental autoimmune encephalitis

Kerstin Renner et al.

JCI INSIGHT (2016)

Add to Collection

Review Neurosciences

Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death

Daniela Rossi

PROGRESS IN NEUROBIOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity

Yao Yao et al.

NATURE COMMUNICATIONS (2014)

Add to Collection

Article Neuroimaging

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Paul K. Crane et al.

BRAIN IMAGING AND BEHAVIOR (2012)

Add to Collection

Article Clinical Neurology

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

William T. Hu et al.

NEUROLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden

Steven John Kiddle et al.

PLOS ONE (2012)

Add to Collection

Article Biochemical Research Methods

Modeling of Pathological Traits in Alzheimer's Disease Based on Systemic Extracellular Signaling Proteome

Markus Britschgi et al.

MOLECULAR & CELLULAR PROTEOMICS (2011)

Add to Collection

Article Clinical Neurology

IL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration

A. Zambrano et al.

CURRENT ALZHEIMER RESEARCH (2010)

Add to Collection

Review Clinical Neurology

Blood Protein Signature for the Early Diagnosis of Alzheimer Disease

Markus Britschgi et al.

ARCHIVES OF NEUROLOGY (2009)

Add to Collection

Editorial Material Psychiatry

Interleukin 3 and schizophrenia

Xiangning Chen et al.

AMERICAN JOURNAL OF PSYCHIATRY (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray et al.

NATURE MEDICINE (2007)

Add to Collection

Article Neurosciences

Interleukin-3 prevents neuronal death induced by amyloid peptide

Angara Zambrano et al.

BMC NEUROSCIENCE (2007)

Add to Collection

Article Hematology

Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia

Julius Juarez et al.

HAEMATOLOGICA (2007)

Add to Collection

Article Neurosciences

Signaling through JAK2-STAT5 pathway is essential for IL-3-Induced activation of microglia

JJ Bright et al.

GLIA (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.